Abstract
Background: Alzheimer's disease is the most common form of dementia, characterized by loss of neurons and synapses in the cerebral cortex and certain subcortical regions, leading to altered and unsuitable activities. In this study, we focused on the influence of rndom selection (RS) and SOMs (self-organizing maps) data splitting on the external predictivity of quantitative structure-property relationship (QSPR) models of some N-ary derivatives as butyrylcholinesterase (BChE) inhibitors. A QSPR model relates molecular descriptors to a chemical property can save time and money in drug discovery and development. Model validation is a critical step in QSPR model generation; for this purpose, it is necessary to carry out the data splitting on original data set. The GA is very useful for finding global minima for high dimensionality of the problem (e.g. variable selection in QSPR) when response surface has many local optima.
Methods: The molecular structures and experimental values for inhibition constants of BChE catalytic activities obtained from the literature. In this study, total number of 88 compounds was divided into training and test set by means of RS and SOM methods. The Chem3D module was used in order to create the 3D structures of compounds; geometry optimization, using the Polak-Ribiere algorithm. Using Dragon package over 1145 molecular descriptors such as 3D-MoRSE, GETAWAY and WHIM descriptors were derived to characterize the structures of ChEs inhibitors derivatives, properly. The constant variables, variables which have low correlation with response and collinear descriptors were omitted, and the number of descriptors was reduced to 422 in the data set. The QSAR models were constructed using stepwise-MLR and GA-MLR.
Results: The best MLR models with four, five and six variables were built to obtain the best QSAR model. The best multivariate linear models in both stepwise-MLR and GA-MLR methods had five variables. The best significant relationships, using comparison of Q2 of models, for logki values of BChE catalytic activity inhibition in the models obtained in S-MLR and GA-MLR methods are presented for all of the random sets and SOM set.
Conclusion: The results of this study showed that a GA-MLR generally performs better than stepwise-MLR. The five variable models were chosen as the best models after evaluating the other models in both GA-MLR and S-MLR methods. The Q2 results indicate that the test set consists of compounds that are evenly distributed within the chemical space; hence, in QSPR modeling, rational splitting methods such as SOM rather than random selection should be used. Also, the Q2 comparison of GA-MLR and stepwise-MLR methods highlights the power of GA-MLR for feature selection. According to the interpretation of QSPR descriptors indicates that, QSAR equation can be useful in designing new N-aryl derivatives as butyrylcholinesterase inhibitors compounds with improved inhibition catalytic activity
Keywords: QSPR, N-aryl substituted derivatives, S-MLR, GA-MLR, random splitting, self-organizing maps.
Graphical Abstract
Current Drug Discovery Technologies
Title:Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors
Volume: 13 Issue: 4
Author(s): Shahin Ahmadi and Soroush Ganji
Affiliation:
Keywords: QSPR, N-aryl substituted derivatives, S-MLR, GA-MLR, random splitting, self-organizing maps.
Abstract: Background: Alzheimer's disease is the most common form of dementia, characterized by loss of neurons and synapses in the cerebral cortex and certain subcortical regions, leading to altered and unsuitable activities. In this study, we focused on the influence of rndom selection (RS) and SOMs (self-organizing maps) data splitting on the external predictivity of quantitative structure-property relationship (QSPR) models of some N-ary derivatives as butyrylcholinesterase (BChE) inhibitors. A QSPR model relates molecular descriptors to a chemical property can save time and money in drug discovery and development. Model validation is a critical step in QSPR model generation; for this purpose, it is necessary to carry out the data splitting on original data set. The GA is very useful for finding global minima for high dimensionality of the problem (e.g. variable selection in QSPR) when response surface has many local optima.
Methods: The molecular structures and experimental values for inhibition constants of BChE catalytic activities obtained from the literature. In this study, total number of 88 compounds was divided into training and test set by means of RS and SOM methods. The Chem3D module was used in order to create the 3D structures of compounds; geometry optimization, using the Polak-Ribiere algorithm. Using Dragon package over 1145 molecular descriptors such as 3D-MoRSE, GETAWAY and WHIM descriptors were derived to characterize the structures of ChEs inhibitors derivatives, properly. The constant variables, variables which have low correlation with response and collinear descriptors were omitted, and the number of descriptors was reduced to 422 in the data set. The QSAR models were constructed using stepwise-MLR and GA-MLR.
Results: The best MLR models with four, five and six variables were built to obtain the best QSAR model. The best multivariate linear models in both stepwise-MLR and GA-MLR methods had five variables. The best significant relationships, using comparison of Q2 of models, for logki values of BChE catalytic activity inhibition in the models obtained in S-MLR and GA-MLR methods are presented for all of the random sets and SOM set.
Conclusion: The results of this study showed that a GA-MLR generally performs better than stepwise-MLR. The five variable models were chosen as the best models after evaluating the other models in both GA-MLR and S-MLR methods. The Q2 results indicate that the test set consists of compounds that are evenly distributed within the chemical space; hence, in QSPR modeling, rational splitting methods such as SOM rather than random selection should be used. Also, the Q2 comparison of GA-MLR and stepwise-MLR methods highlights the power of GA-MLR for feature selection. According to the interpretation of QSPR descriptors indicates that, QSAR equation can be useful in designing new N-aryl derivatives as butyrylcholinesterase inhibitors compounds with improved inhibition catalytic activity
Export Options
About this article
Cite this article as:
Ahmadi Shahin and Ganji Soroush, Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors, Current Drug Discovery Technologies 2016; 13 (4) . https://dx.doi.org/10.2174/1570163813666160725114241
DOI https://dx.doi.org/10.2174/1570163813666160725114241 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Role of Zonisamide in Neuropsychiatric Disorders
Mini-Reviews in Medicinal Chemistry Patents on Potential Drugs to Treat Alzheimer’s Disease: Special Emphasis on Small Peptides
Recent Patents on CNS Drug Discovery (Discontinued) Diabetes Exacerbates Nanoparticles Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research Obstructive Sleep Apnea Syndrome and Upper Airway Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutic Strategies for Huntingtons Disease: From the Bench to the Clinic
Current Psychopharmacology Cutaneomeningospinal Angiomatosis (Cobb Syndrome) in a Young Patient
CNS & Neurological Disorders - Drug Targets Alzheimers Disease - An Interactive Perspective
Current Alzheimer Research Key Peptides and Proteins in Alzheimer’s Disease
Current Protein & Peptide Science Antioxidant Status and Energy State of Erythrocytes in Alzheimer Dementia: Probing for Markers
CNS & Neurological Disorders - Drug Targets The Impact of Marijuana Use on Memory in HIV-Infected Patients: A Comprehensive Review of the HIV and Marijuana Literatures
Current Drug Abuse Reviews MMP Inhibitors in Cardiac Diseases: An Update
Recent Patents on Cardiovascular Drug Discovery Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?
Current Pharmaceutical Design Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment
Current Pharmaceutical Biotechnology Current Role and Future Perspectives of Radioiodinated MIBG in the Evaluation of Dementia with Lewy Bodies
Current Radiopharmaceuticals PET Molecular Imaging of Hypoxia in Ischemic Stroke: An Update
Current Vascular Pharmacology Hematologic Abnormalities in the Antiphospholipid Syndrome
Current Rheumatology Reviews Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Current Topics in Medicinal Chemistry Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
CNS & Neurological Disorders - Drug Targets